A high rate silicon detector and front-end electronics prototype for single ion discrimination in particle therapy

The medical physics group of the Turin section of the National Institute of Nuclear Physics, on the behalf of the MoVeIT collaboration, is working for the development of a new prototype of silicon strip detector for particle therapy applications. This device, based on 50 \mu m thin silicon sensors with internal gain, aims to detect the single beam particle and count their number up to 10^{8} cm^{2}/s fluxes, with a pileup probability < 1%. A similar approach would lead to a drastic step forward, compared to the classical and widely used monitoring system based on ionization chambers. The better sensitivity, the higher dynamic range and the fact that the particle counting is independent of the beam energy, pressure and temperature, make this silicon detector suitable for the on-line dose monitoring in particle therapy applications. The prototype detector will cover a 3X3 cm^{2} area and at the moment, two sets of strip sensors with different geometry and custom design, have been produced and are currently under investigation. The classic orthogonal strip positioning is used for beam profile measures. For what concerns the front-end electronics, the design of two different solutions is ongoing: one based on a transimpedance preamplifier, with a resistive feedback and the second one based on a charge sensitive amplifier. The challenging task for the design is the expected 3 fC -130 fC wide input charge range (due to the Landau fluctuation spreading and different beam energies), dealing with a hundreds of MHz instantaneous rate (from 200 MHz up to 500 MHz ideally). To effectively design these components, it is crucial to perform preliminary investigation of the sensor response to the expected stimuli. For this reason an extensive work has been done and is still on going, using 1.2 mm ^{2} area and 50 \mu m silicon pads with gain, performing test with the clinical beam of the Italian National Center of Oncological Hadrontherapy (CNAO) in Pavia, Italy.